Key statistics
As of last trade Immunovia AB (publ) (0G8X:LSE) traded at 0.695, 0.00% above its 52-week low of 0.695, set on Oct 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 0.695 |
Low | 0.695 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 169.71m |
Free float | 131.71m |
P/E (TTM) | -- |
Market cap | 98.43m SEK |
EPS (TTM) | -1.30 SEK |
Data delayed at least 20 minutes, as of Oct 09 2024 10:24 BST.
More ▼
Press releases
- Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers
- Invitation to Immunovia's Q3 presentation
- Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
More ▼